ESSA Financial Statements From 2010 to 2026
| EPIXDelisted Stock | USD 0.20 0.00 0.00% |
Check ESSA Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ESSA Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . ESSA financial statements analysis is a perfect complement when working with ESSA Pharma Valuation or Volatility modules.
ESSA |
ESSA Pharma Company Shares Outstanding Analysis
ESSA Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current ESSA Pharma Shares Outstanding | 47.31 M |
Most of ESSA Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ESSA Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, ESSA Pharma has 47.31 M of shares currently outstending. This is 73.8% lower than that of the Biotechnology sector and 55.73% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 91.73% higher than that of the company.
ESSA Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ESSA Pharma's current stock value. Our valuation model uses many indicators to compare ESSA Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ESSA Pharma competition to find correlations between indicators driving ESSA Pharma's intrinsic value. More Info.ESSA Pharma is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ESSA Pharma's earnings, one of the primary drivers of an investment's value.About ESSA Pharma Financial Statements
ESSA Pharma investors use historical fundamental indicators, such as ESSA Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ESSA Pharma. Please read more on our technical analysis and fundamental analysis pages.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. Essa Pharma is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in ESSA Stock
If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |